SCHEMBL31028678

SCHEMBL31028678

Cc1ccc(S(N)(=O)=O)c(F)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.38
PTGS1 P23219 2/20 0.38
CA1 P00915 8/20 0.38
CA2 P00918 8/20 0.38
CA9 Q16790 8/20 0.38
CA12 O43570 6/20 0.38
CA14 Q9ULX7 3/20 0.38
GAA P10253 1/20 0.37
CA7 P43166 3/20 0.37
CA13 Q8N1Q1 2/20 0.37
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ACSS2 Q9NR19 1/20 0.36
CA6 P23280 2/20 0.35
CA4 P22748 1/20 0.35
PDIA6 Q15084 1/20 0.35
TET2 Q6N021 1/20 0.35
CA3 P07451 1/20 0.34
CA5A P35218 1/20 0.34
CA5B Q9Y2D0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31028677 1.00 PTGS2 (0.38) PTGS2PTGS1CA1CA2CA9
SCHEMBL31645084 0.80 KMT2A (0.36) CA1CA2CA12GAACA7
SCHEMBL31028743 0.79 TET2 (0.37) PTGS2PTGS1CA1CA2CA9
SCHEMBL18200089 0.79 CA1 (0.39) CA1CA2CA9CA12CA14
SCHEMBL31028687 0.76 KMT2A (0.41) CA1CA2CA9CA12CA14
SCHEMBL31028711 0.72 PTGS2 (0.38) PTGS2PTGS1CA1CA2CA9
SCHEMBL13003518 0.71
SCHEMBL31082078 0.71
SCHEMBL31028700 0.71 KDM4E (0.39) PTGS2PTGS1CA1CA2CA9
SCHEMBL4178175 0.68 CA1 (0.59) CA1CA2CA9CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024115549-A1 ARYL- AND HETEROARYL-SULFONAMIDE DERIVATIVES AS CCR8 MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-06 WO claimed
WO-2024115549-A1 ARYL- AND HETEROARYL-SULFONAMIDE DERIVATIVES AS CCR8 MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-06 WO disclosed